Dr. Hermel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10710 N Torrey Pines Rd
La Jolla, CA 92037Phone+1 858-554-8788Fax+1 858-554-8946
Summary
- Dr. David Hermel is currently a hematologist at Scripps Clinic in La Jolla, CA. He completed his fellowship in hematology and oncology at Scripps Clinic and his residency training in internal medicine at the University of Southern California. He received his medical degree from the University of Vermont College of Medicine and completed undergraduate studies at the University of California, Los Angeles.
Education & Training
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2016 - 2019
- University of Vermont College of MedicineClass of 2016
Certifications & Licensure
- CA State Medical License 2017 - 2027
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular.Danielle Brazel, David Hermel, Pranav Gandhi, Alan Saven
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-01 - 3 citationsHairy cell leukemia variant and WHO classification correspondence Re: 5edition WHO classification haematolymphoid tumors: lymphoid neoplasms.Michael Grever, Leslie Andritsos, Mirela Anghelina, Evgeny Arons, Versha Banerji
Leukemia. 2024-07-01 - 2 citationsDo patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?Aren Ebrahimi, Jason Cham, Leah Puglisi, Melanie De Shadarevian, David J Hermel
Cancer Medicine. 2023-05-01
Journal Articles
- Progress in gastrointestinal cancer immunotherapyDavid J. Hermel, Melody H. Hermel, Darren S. Sigal, Translational Cancer Research, 2/2017
- “Check”-ing the Data: A Review of Immune Checkpoint Inhibitor BiomarkersHermel D, Sigal D, Personalized Medicine in Oncology, 8/1/2016
Books/Book Chapters
Abstracts/Posters
- Expanded Panel Testing in Patients with Breast or Ovarian Cancer in a Rural Familial Cancer ProgramHermel D.J., McKinnon W.C., Colello L., Greenblatt M.S., Wood M.E, Cancer Research
- Tacrolimus Is Effective Immunosuppressive Therapy in Aplastic AnemiaChiu V., Hermel D.J., Weitz I.C, Blood
- PD-1 Inhibition in Cutaneous Squamous Cell CarcinomaHermel D.J., Ragab O., Higgins S., Wysong A., In G.K, ASCO
- Join now to see all
Press Mentions
- Reducing Hospital Length of Stay for AML Patients on High-Dose CytarabineDecember 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: